Status:
COMPLETED
Chronic Total Coronary Occlusion Treatment Results 6 Years After Bioresorbable Scaffold Implantation
Lead Sponsor:
Pauls Stradins Clinical University Hospital
Conditions:
Angina Pectoris
Coronary Artery Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
Aim of the study is to evaluate chronic total coronary occlusion treatment results 6 years after bioresorbable scaffold implantation by quantitative coronary analysis, intravascular ultrasound and opt...
Detailed Description
The study aims to assess the outcomes of treating chronic total coronary occlusion (CTO) using bioresorbable scaffolds six years after implantation. The evaluation employs quantitative coronary analys...
Eligibility Criteria
Inclusion
- 100% occlusion of a coronary artery for a duration of greater than or equal to 3 months based on angiographic evidence.
Exclusion
- Participant withdrawal from study.
Key Trial Info
Start Date :
February 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06164977
Start Date
February 1 2017
End Date
December 1 2023
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pauls Stradins Clinical University Hospital
Riga, Rīga, Latvia, LV-1002